These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. Ferrantelli F; Buckley KA; Rasmussen RA; Chalmers A; Wang T; Li PL; Williams AL; Hofmann-Lehmann R; Montefiori DC; Cavacini LA; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM Virology; 2007 Feb; 358(1):69-78. PubMed ID: 16996554 [TBL] [Abstract][Full Text] [Related]
13. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111 [TBL] [Abstract][Full Text] [Related]
14. Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission? Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Smith BA; Baba TW; Liska V; Montefiori DC; McClure HM; Anderson DC; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Katinger H; Stiegler G; Posner MR; Cavacini LA; Chou TC; Ruprecht RM J Med Primatol; 2001 Aug; 30(4):190-6. PubMed ID: 11555137 [TBL] [Abstract][Full Text] [Related]
15. Antibody protection: passive immunization of neonates against oral AIDS virus challenge. Ruprecht RM; Ferrantelli F; Kitabwalla M; Xu W; McClure HM Vaccine; 2003 Jul; 21(24):3370-3. PubMed ID: 12850342 [TBL] [Abstract][Full Text] [Related]
16. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys. Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869 [TBL] [Abstract][Full Text] [Related]
17. Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies. Mascola JR; Lewis MG; VanCott TC; Stiegler G; Katinger H; Seaman M; Beaudry K; Barouch DH; Korioth-Schmitz B; Krivulka G; Sambor A; Welcher B; Douek DC; Montefiori DC; Shiver JW; Poignard P; Burton DR; Letvin NL J Virol; 2003 Oct; 77(19):10348-56. PubMed ID: 12970419 [TBL] [Abstract][Full Text] [Related]
18. Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques. Ferrantelli F; Hofmann-Lehmann R; Rasmussen RA; Wang T; Xu W; Li PL; Montefiori DC; Cavacini LA; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM AIDS; 2003 Feb; 17(3):301-9. PubMed ID: 12556683 [TBL] [Abstract][Full Text] [Related]
19. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques. Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476 [TBL] [Abstract][Full Text] [Related]
20. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]